Picture of Sensorion SA logo

ALSEN — Sensorion SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Sensorion Is Financed With Cash Runway That Extends Until H2 2022

Feb 1 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION IS NOW FINANCED THROUGH A NUMBER OF KEY VALUE
INFLECTION POINTS WITH A CASH RUNWAY THAT EXTENDS UNTIL H2 2022
    * STUDY IN SUDDEN SENSORINEURAL HEARING LOSS: GROUP EXPECTS
RESULTS FROM PHASE II STUDY IN Q4 2021
    * WE ALSO ANTICIPATE INITIATING A PROOF-OF-CONCEPT CLINICAL
STUDY
OF SENS-401 IN CISPLATIN INDUCED OTOTOXICITY (CIO) IN H2 2021
    * GROUP WILL ALSO REMAIN ACTIVE IN PROGRESSING ITS
PARTNERSHIP
PROGRAMS
    * SENSORION AND COCHLEAR ARE ASSESSING POSSIBILITY OF
CONDUCTING
CLINICAL STUDIES FOR SENS-401 IN COCHLEAR IMPLANT PATIENTS

Source text for Eikon:  ID:nNDL1cyZSj 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; 48 58 7696600;))

Recent news on Sensorion SA

See all news